The Latest Breaking News from CMS

The Child Maintenance Service is getting new powers to help track down parents who don't pay their child support, with pension and insurance firms now ordered to give data if asked

Medicare has proposed limiting coverage of Aduhelm. Key groups representing patients and families are pressing to make it more widely available. Among people facing the disease, the outlook is more nuanced.

If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might think everyone living with Alzheimer’s wants unfettered access to Aduhelm, a controversial new treatment.

As a parting gesture to a pandemic-ravaged city, former New York Mayor Bill de Blasio hoped to provide the city with a gift that would keep on giving: new health insurance for 250,000 city retirees partly funded by the federal government. Although he promised better benefits and no change in…

The child maintenance system is still heavily biased against women – and our system for addressing that is a shambles, says Guardian columnist Polly Toynbee

The Biden administration has identified core impediments to better nursing home care in its proposed overhaul of the industry, but turning aspirations into reality will require a complex task: mandating adequate staffing levels for all homes without bankrupting those that can’t afford far higher labor costs.

Analysts have provided the following ratings for CMS Energy (NYSE:CMS) within the last quarter:

The drug industry, patient advocates and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug. They’ve gone as far as to accuse them of tacit racism, ageism and discrimination against the disabled — and hinted at a lawsuit — over the…

WASHINGTON — Advocates on both sides of a debate over dramatically restricting Medicare’s coverage of an expensive and controversial Alzheimer’s treatment are waging competing campaigns to influence a final decision in April.

Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.

A group of states is renewing a challenge to President Joe Biden's requirement that millions of healthcare workers across the U.S. be vaccinated